The Medical Editors at MDLinx.com diligently work around the clock to provide the most current Physician Assistant medical news articles from over 2,000 peer-reviewed clinical journals. Our coverage includes over 32 specialties and 800 subspecialties, perfect for the multidisciplinary practice of today’s PAs. Topics include: everything from Anesthesiology to Women’s Health, plus Economics of Medicine, Popular Press, Teaching Hospital News, and much more. In less than 5 minutes a day, Physician Assistants can be updated with the latest published information from thousands of journals after consulting just one resource.
Join MDLinx today to learn more about upcoming PA conferences and CME opportunities for Physician Assistants, search PA job listings, receive daily newsletters and earn extra cash by participating in Market Research studies.
1 Omega-3 supplements for patients in chemotherapy and/or radiotherapy: A systematic review Clinical Nutrition, November 21, 2014 Clinical Article
2 FTY720, a sphingosine-1-phosphate (S1P) receptor modulator, protects sinusoid endothelial cells from radiation injury in vitro Hepatology International, November 21, 2014 Clinical Article
3 Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection Hepatology International, November 21, 2014 Clinical Article
4 Experimental validation of frequently-used echocardiographic right-ventricular impedance parameters Minerva Anestesiologica, November 21, 2014 Clinical Article
5 Cerebral venous thrombosis in inflammatory bowel disease: A case series Journal of Digestive Diseases, November 21, 2014 Clinical Article
6 Effect of reoperation on long-term outcome of pT1b/T2 gallbladder carcinoma after initial laparoscopic cholecystectomy Journal of Gastrointestinal Surgery, November 21, 2014 Clinical Article
7 The growth of Medicare rebatable cone beam CT and panoramic radiography in Australia Australian Dental Journal, November 21, 2014 Clinical Article
8 Beneficial effect of the 5-HT1A receptor agonist buspirone on esophageal dysfunction associated with systemic sclerosis: A pilot study United European Gastroenterology Journal, November 21, 2014 Clinical Article
9 Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: A phase 1/2 trial The Lancet Oncology, November 21, 2014 Clinical Article
10 Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): A phase 3, multicentre, randomised trial The Lancet Oncology, November 21, 2014 Clinical Article
11 American society of clinical oncology policy statement on medicaid reform Journal of Clinical Oncology, November 21, 2014 Clinical Guideline
12 Evaluation of the national comprehensive cancer network and American Urological Association renal cell carcinoma surveillance guidelines Journal of Clinical Oncology, November 21, 2014 Clinical Guideline
13 Impact of spin in the abstracts of articles reporting results of randomized controlled trials in the field of cancer: The SPIIN randomized controlled trial Journal of Clinical Oncology, November 21, 2014 Clinical Article
14 Law enforcement duties and sudden cardiac death among police officers in United States: case distribution study BMJ, November 21, 2014 Evidence Based Medicine
15 Use of cardiac biomarker testing in the emergency department JAMA Internal Medicine, November 21, 2014 Evidence Based Medicine Clinical Article
16 Medication therapy management interventions in outpatient settings: a systematic review and meta-analysis JAMA Internal Medicine, November 21, 2014 Evidence Based Medicine Review Article Clinical Article
17 Effects of hyperbaric oxygen on symptoms and quality of life among service members with persistent postconcussion symptoms: a randomized clinical trial JAMA Internal Medicine, November 21, 2014 Evidence Based Medicine Clinical Article
18 Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis Annals of Oncology, November 21, 2014 Evidence Based Medicine
19 Concomitant ALK translocation and EGFR mutation in lung cancer: A comparison of direct sequencing and sensitive assays and the impact on responsiveness to tyrosine kinase inhibitor Annals of Oncology, November 21, 2014 Clinical Article
20 Temporal lobe impairment in West syndrome: Event-related potential evidence Annals of Neurology , November 21, 2014 Clinical Article
Based on a meta-analysis reported in BMC Medicine, NSAID use is associated with a decreased risk of prostate cancer (OR=0.92 [total] and 0.81 [advanced]) and prostate cancer-specific mortality (HR=0.86 [total] and 0.81 [advanced]).
As reported in JAMA—Otolaryngology-Head & Neck Surgery, patients with salivary gland tumors have an increased risk of second primary tumors and newly developed cancers. Specifically, the cumulative 2-, 5-, and 10-year rates for second primary cancers are 4.4%, 8.3%, and 12.4%, respectively. Similarly, the cumulative 2-, 5-, and 10-year rates for newly diagnosed cancers are 1.1%, 3.4%, and 10.5%, respectively.
As reported in the International Journal of Clinical Oncology, the 5-year biochemical recurrence (BCR)-free survival rate is significantly higher in patients with a 3-month PSA level < 0.010 ng/ml compared to patients with a 3-month PSA level between 0.010 and 100 ng/ml (92.6% vs. 57.4%). Amongst 174 men who underwent radical prostatectomy for clinically localized prostate cancer, 18.4% had a BCR and the median time to BCR was 16 months.